In addition, we explored the therapeutic effect of the synthetic HIF-1α/STAT5 decoy ODN using a mouse model with DNCB/DfE-sensitized AD-like allergy inflammation and a IgE+Ag-treated mast-cell-like cell line. This evidence concerns the gene HIF1A and allergic disease.